Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases

Scientific Data

Volumn 3, Issue , 2016, Pages

  Allen, Mariet ^a   Carrasquillo, Minerva M ^a   Funk, Cory ^b   Heavner, Benjamin D ^b   Zou, Fanggeng ^a   Younkin, Curtis S ^c   Burgess, Jeremy D ^a   Chai, High Seng ^d   Crook, Julia ^b   Eddy, James A ^b   Li, Hongdong ^b   Logsdon, Ben ^e   Peters, Mette A ^e   Dang, Kristen K ^e   Wang, Xue ^c   Serie, Daniel ^c   Wang, Chen ^d   Nguyen, Thuy ^a   Lincoln, Sarah ^a   Malphrus, Kimberly ^a   Bisceglio, Gina ^a   Li, Ma ^a   Golde, Todd E ^f   Mangravite, Lara M ^e   Asmann, Yan ^b   Price, Nathan D ^b   Petersen, Ronald C ^d   Graff Radford, Neill R ^c   Dickson, Dennis W ^a   Younkin, Steven G ^a   Ertekin Taner, Nilüfer ^a,c   more..

^a MAYO GRADUATE SCHOOL   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

^e SAGE BIONETWORKS   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN GENOME;

ALZHEIMER DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEURODEGENERATIVE DISEASES; TRANSCRIPTOME;

EID: 84991063120     PISSN: None     EISSN: 20524463     Source Type: Journal    
DOI: 10.1038/sdata.2016.89     Document Type: Article

References (36)

1. Carrasquillo, M. M. et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet 41, 192-198 (2009).
2. Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature genetics 41, 1088-1093 (2009).
3. Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature genetics 41, 1094-1099 (2009).
4. Seshadri, S. et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. Jama 303, 1832-1840 (2010).
5. Naj, A. C. et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature genetics 43, 436-441 (2011).
6. Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature genetics 43, 429-435 (2011).
7. Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature genetics 45, 1452-1458 (2013).
8. Hoglinger, G. U. et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature genetics 43, 699-705 (2011).
9. Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature genetics 41, 1308-1312 (2009).
10. Zou, F. et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 8, e1002707 (2012).
11. Dixon, A. L. et al. A genome-wide association study of global gene expression. Nature genetics 39, 1202-1207 (2007).
12. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423-428 (2008).
13. Saykin, A. J. et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, plans. Alzheimers Dement 11, 792-814 (2015).
14. Zou, F. et al. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology 74, 480-486 (2010).
15. Allen, M. et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology 79, 221-228 (2012).
16. Allen, M. et al. Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener 7, 13 (2012).
17. Allen, M. et al. Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. Alzheimers Res Ther 6, 39 (2014).
18. Allen, M et al. Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurology: Genetics 1, e15 (2015).
19. Myers, A. J. et al. A survey of genetic human cortical gene expression. Nature genetics 39, 1494-1499 (2007).
20. Webster, J. A. et al. Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84, 445-458 (2009).
21. Chapuis, J. et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18, 1225-1234 (2013).
22. Hazrati, L. N. et al. Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism. Neurobiol Aging 33, 2949 e5-2949 e12 (2012).
23. Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 17, 1418-1428 (2014).
24. Montgomery, S. B. et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464, 773-777 (2010).
25. Derry, J. M. et al. Developing predictive molecular maps of human disease through community-based modeling. Nature genetics 44, 127-130 (2012).
26. Allen, M. et al. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol 132, 197-211 (2016).
27. McKhann, G et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
28. Farrer, LA et al. Effects of age, sex, ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 278, 1349-1356 (1997).
29. Braak, H., Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82, 239-259 (1991).
30. Hauw, J. J. et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015-2019 (1994).
31. Mirra, S. S. et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 53, 303-315 (1994).
32. Wang, J., Dickson, D. W., Trojanowski, J. Q., Lee, V. M. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol 158, 328-337 (1999).
33. Du, P., Kibbe, W. A., Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
34. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575 (2007).
35. Magis, A. T., Funk, C. C., Price, N. D. SNAPR: A Bioinformatics Pipeline for Efficient and Accurate RNA-Seq Alignment and Analysis. IEEE Life Sciences Letters 1, 22-25 (2015).
36. Funk, C. AMP-AD-scripts: AMP-AD Fl-Mayo-ISB. in Zenodo https://dx.doi.org/10.5281/zenodo.56828 (2016).